Amgen had set its business up as an innovator that produced cutting-edge products. The biosimilar business was lucrative purely on business but would dilute its image. It was widely thought that changes in the business model would affect its reputation as an innovator. Resources would also have to be diverted to the new course, and that presented a significant bottleneck.
What are the arguments against Amgen’s going into the biosimilar business?
Answer by Academic.tip's expert
An answer to this question is provided by one of our experts who specializes in business & economics. Let us know how much you liked it and give it a rating.
Cite this page
Select a citation style:
References
Academic.Tips. (2023) 'What are the arguments against Amgen's going into the biosimilar business'. 12 March.
Reference
Academic.Tips. (2023, March 12). What are the arguments against Amgen's going into the biosimilar business? https://academic.tips/question/what-are-the-arguments-against-amgens-going-into-the-biosimilar-business/
References
Academic.Tips. 2023. "What are the arguments against Amgen's going into the biosimilar business?" March 12, 2023. https://academic.tips/question/what-are-the-arguments-against-amgens-going-into-the-biosimilar-business/.
1. Academic.Tips. "What are the arguments against Amgen's going into the biosimilar business?" March 12, 2023. https://academic.tips/question/what-are-the-arguments-against-amgens-going-into-the-biosimilar-business/.
Bibliography
Academic.Tips. "What are the arguments against Amgen's going into the biosimilar business?" March 12, 2023. https://academic.tips/question/what-are-the-arguments-against-amgens-going-into-the-biosimilar-business/.
Work Cited
"What are the arguments against Amgen's going into the biosimilar business?" Academic.Tips, 12 Mar. 2023, academic.tips/question/what-are-the-arguments-against-amgens-going-into-the-biosimilar-business/.
Copy